My.Alpha Management Hk Advisors LTD Bei Gene, Ltd. Transaction History
My.Alpha Management Hk Advisors LTD
- $235 Million
- Q3 2024
A detailed history of My.Alpha Management Hk Advisors LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, My.Alpha Management Hk Advisors LTD holds 69,762 shares of BGNE stock, worth $12.3 Million. This represents 6.66% of its overall portfolio holdings.
Number of Shares
69,762Holding current value
$12.3 Million% of portfolio
6.66%Shares
1 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.87 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.14 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$914 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$878 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$654 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $18.3B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...